Trinity Biotech PLC

160 articles with Trinity Biotech PLC

• Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results

  3/25/2021

  Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced results for the quarter ended December 31, 2020 and fiscal year 2020.

• Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2020 Financial ResultsConference Call Scheduled for March 25, 2021 at 11:00 am EASTERN

  3/23/2021

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2020 on Thursday, March 25, 2021.

• Trinity Biotech Announces Results for Q3, 2020

  11/17/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2020. Quarter 3 Results Total revenues for Q3, 2020 were $32.0m, which is broken down as follows:   2019 Quarter 3 2020 Quarter 3 Change   US$’000 US$’000 % Point-of-Care 3,880 2,065 (46.8)% Cl

• Trinity Biotech plc to Announce Third Quarter 2020 Financial ResultsConference Call Scheduled for November 17, 2020 at 11:00 am EASTERN

  10/29/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter 2020 on Tuesday, November 17, 2020. The Company has scheduled a conference call for that same day, Tuesday, November 17, 2020 at 11:00am ET (4:00pm GMT) to discuss the results of the quarter. Interested parties can access the call by dialing: US Tol

• Trinity Biotech Announces Results for Q2, 2020

  8/25/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2020.

• Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test

  8/20/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets announced that it has filed its submission for an Emergency Use Authorization (EUA) for its Covid-19 IgG ELISA antibody test with the FDA. This test will determine which individuals within the population have been exposed to the SARS-CoV-2 virus. The transfer of production to our facility in Jame

• Trinity Biotech plc to Announce Second Quarter 2020 Financial ResultsConference Call Scheduled for August 25, 2020 at 11:00am EASTERN

  8/18/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter 2020 on Tuesday, August 25, 2020. The Company has scheduled a conference call for that same day, Tuesday, August 25, 2020 at 11:00am ET (4:00pm BST) to discuss the results of the quarter. Interested parties can access the call by dialing:

• Trinity Biotech subsidiary, Primus Corporation Receives FDA Warning Letter

  8/17/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced that its subsidiary Primus Corporation has received a warning letter from the U.S. Food and Drug Administration (FDA) following an inspection of its Kansas City, Missouri manufacturing facility that took place in January 2020. The issues identified in this letter primarily relate to th

• Trinity Biotech Announces Results for Q1, 2020

  5/27/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2020.

• Trinity Biotech plc to Announce First Quarter 2020 Financial ResultsConference Call Scheduled for May 27, 2020 at 11:00am EASTERN

  5/14/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter 2020 on Wednesday, May 27, 2020. The Company has scheduled a conference call for that same day, Wednesday, May 27, 2020 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.  Interested parties can access the call by dialing:  

• Trinity Biotech announces Quarter 4 and Fiscal Year 2019 Financial Results

  3/31/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2019 and fiscal year 2019.

• Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2019 Financial ResultsConference Call Scheduled for March 31, 2020 at 11:00am EASTERN

  3/24/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2019 on Tuesday, March 31, 2020.

• Trinity Biotech Announces Results for Q3, 2019

  10/16/2019

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2019.

• Trinity Biotech plc to Announce Third Quarter Fiscal Year 2019 Financial ResultsConference Call Scheduled for October 16, 2019 at 11:00 am EASTERN

  10/15/2019

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2019 on Wednesday, October 16, 2019.

• Trinity Biotech Announces Results for Q3, 2017

  10/26/2017

  Total revenues for Q3, 2017 were $25.6 million.

• Trinity Biotech To Announce 2017 Third Quarter Financial Results

  10/13/2017

• Trinity Biotech Announces Results for Q2, 2017

  7/20/2017

• Trinity Biotech Announces Results For Q1, 2017

  4/27/2017

• Trinity Biotech To Announce First Quarter Fiscal Year 2017 Financial Results

  4/18/2017

• Trinity Biotech Cuts Jobs in Shutdown of Swedish Facility, Withdraws Device App With the FDA

  10/4/2016